CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...